Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies. Tekijä Sandborn, W, Danese, S, D'Haens, G, Moro, L, Jones, R, Bagin, R, Huang, M, David Ballard, E, Masure, J, Travis, S

Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study. Tekijä Travis, S, Danese, S, Kupcinskas, L, Alexeeva, O, D'Haens, G, Gibson, P, Moro, L, Jones, R, Ballard, E, Masure, J, Rossini, M, Sandborn, W